News / Research & Innovation

Respiratory specialists at The Alfred are urging people with asthma to review their medication after new research found one quarter of people who use inhaler controllers receive potentially toxic cumulative doses of oral corticosteroid.

Artificial intelligence (AI) could soon become a powerful tool in skin cancer assessment. The Victorian Melanoma Service is currently conducting a trial into the effectiveness of the technology. 

Making up 80 per-cent of all brain tumours in adults, gliomas such as glioblastoma (GBM) are the most common and aggressive form of brain cancer. Killing more people under forty than any other cancer, a quarter of a million people die every year from these tumours – despite current treatment options the average survival for a GBM is only 14-15 months after diagnosis

Researchers from The Alfred and Monash University have set out to determine whether an antiviral medication used to treat influenza could help people with COVID-19 recover faster.

Before COVID-19 struck, Natalia Rodriguez had been travelling from Launceston to The Alfred Oncology Unit every three weeks to take part in a clinical trial that could save her life.

Dr James McMahon, Infectious Diseases physician and Head of Clinical Research at the Alfred Hospital and Monash University, has his sights set on cracking the immunity code of COVID-19.

The Alfred and Monash University are testing an innovative new machine that could improve the symptoms of people with Parkinson’s Disease using gravity and movement.

Anaesthesiology and Perioperative Medicine director, Professor Paul Myles has become just the eighth Australian elected to the National Academy of Medicine (NAM) in the United States.

Reducing antibiotic use in food-producing animals is critically important to address antibiotic resistance in humans, according to Professor Allen Cheng, Director of Infection Prevention, and Dr Freya Langham.